Bank Artha Graha Internasional Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Artha Graha Internasional Tbk. trades at Rp134 (market cap 2.64T, 1.83M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Bank Artha Graha Internasional Tbk. is far larger — about 15.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Artha Graha Internasional Tbk. is more actively traded (1.83M versus 96.7K). Which is the better fit depends on your goals.
| INPC | OBAT | |
|---|---|---|
Market Cap | 2.64T | 167.37B |
Volume | 1.83M | 96.7K |
Lot | 18.32K | 967 |
Turnover | 245.33M | 23.82M |
Average Price | 133.94 | 246.34 |
Value | 245.33M | 23.82M |
Indicative Equilibrium Price | 134 | 248 |
Indicative Equilibrium Volume | 723 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Artha Graha Internasional Tbk (“the Bank”) initially was established under the name of PT Inter-Pacific Financial Corporation based on notarial deed No. 12 dated September 7, 1973 of Bagijo, SH, substitute notary of Eliza Pondaag, SH, Notary in Jakarta. PT Bank Inter Pacific, Tbk is a joint venture bank that for the previous period of 20 years operated as Non Bank Financial Institution (NBFI) and went public in August 1990.
Read more on INPC →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →